MedPath

GLIADEL WAFER

GLIADEL WAFER

Discontinued
DIN Number

02238985

Drug Class

Human

Market Date

Jul 2, 2002

Company
HC

EISAI LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02238985
AIG Number0109587002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01AD01 CARMUSTINE
Product Specifications
Dosage FormWafer
Route of AdministrationIntralesional
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CARMUSTINEActive
Strength: 7.7 MG
Monograph: CARMUSTINE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.